Specialty Drug Update

Wednesday, February 27, 2019 at 11:00 a.m. CST

Overview

High (specialty drug costs for treating some chronic conditions can be as high as $1 million annually for a single plan member) and rising specialty drug costs have become the most important health plan cost driver for many employer groups. The entry of these drugs into the marketplace has raised important economic, health, and ethical questions for all health plans.

Key takeaways include:

  • The clinical effectiveness of commonly used specialty drugs;
  • The cost impact of these drugs, including ROI estimates and future cost projections;
  • The FDA specialty drug approval pipeline;
  • Ethical issues surrounding the financing and use of these drugs
  • Current options for managing costs and ensuring the appropriate use of these drugs

After this webinar, employers will have a better understanding of specialty drug use, the drug release schedule, and most importantly practical action steps to control costs without adversely affecting members’ health and prognosis.

This webinar is eligible for SHRM, HRCI, and CEBS credits.

About the Speaker

Bruce Campbell, PhD, MD

Dr. Campbell brings over 25 years of executive experience in healthcare, information technology, and managed care to our clients. He has held executive staff and operating positions in healthcare services companies, managed care plans, integrated delivery systems, medical groups and healthcare information technology companies.

Register Below

Securities offered through Registered Representatives of Cambridge Investment Research, Inc., a broker-dealer, member FINRA/SIPC. Advisory services through Cambridge Investment Research Advisors, Inc., a Registered Investment Adviser. JA Counter and Alera Group are not affiliated with Cambridge.

Due to various state regulations and registration requirements concerning the dissemination of information regarding investment and insurance products and services, access to this information must be limited to individuals residing in the following states: AL, AZ, CA, CO, FL, GA, IA, IL, IN, KS, KY, MA, MD, ME, MI, MN, MO, MT, NC, ND, NE, NJ, NV, NY, OH, OK, PA, SC, SD, TN, TX, UT, VA, VT, WA, WI, and WV.

| JA Counter® All Rights Reserved. ©2017